AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 27452896 — intervention group
Group type: COMPARATOR
Intervention: Sham irradiation (control group)
Number of subjects: 44
Study 26090394 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent warm blood cardioplegia (IWC)
Number of subjects: 68
Study 26090394 — intervention group
Group type: COMPARATOR
Intervention: Intermittent cold blood cardioplegia (ICC)
Number of subjects: 68
Study 25447201 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics administered to 5 infants
Number of subjects: 43
Study 25447201 — intervention group
Group type: COMPARATOR
Intervention: No probiotics administered to 38 infants
Number of subjects: 43
Study 25447201 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-trial testing
Number of subjects: 43
Study 22549432 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 2.4 gm/day
Number of subjects: 36
Study 22549432 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 36
Study 22549432 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 19464865 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (30 min treadmill exercise, 3 times per week for 6 weeks)
Number of subjects: 40
Study 19464865 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training
Number of subjects: 40
Study 19464865 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 40
Study 17988315 — intervention group
Group type: EXPERIMENTAL
Intervention: Racism condition (history lessons including information about racism experienced by African Americans)
Number of subjects: 117
Study 17988315 — intervention group
Group type: COMPARATOR
Intervention: Control condition (history lessons that omitted information about racism)
Number of subjects: 117
Study 17988315 — intervention group
Group type: EXPERIMENTAL
Intervention: Racism condition
Number of subjects: 117
Study 17988315 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 117
Study 16128502 — intervention group
Group type: EXPERIMENTAL
Intervention: Software-based telephone counseling
Number of subjects: 366
Study 16128502 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 366
Study 12139206 — intervention group
Group type: EXPERIMENTAL
Intervention: Trospium chloride (20 mg twice daily)
Number of subjects: 517
Study 12139206 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 517
Study 9499701 — intervention group
Group type: EXPERIMENTAL
Intervention: Significant IRS at Session 1
Number of subjects: 48
Study 9499701 — intervention group
Group type: EXPERIMENTAL
Intervention: IRS stability
Number of subjects: 48
Study 9499701 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants with significant IRS at Session 1
Number of subjects: 48
Study 9499701 — intervention group
Group type: EXPERIMENTAL
Intervention: Between-session IRS (trait-IRS)
Number of subjects: 48
Study 9499701 — intervention group
Group type: EXPERIMENTAL
Intervention: Within-session IRS (state-IRS)
Number of subjects: 48
Study 8942402 — intervention group
Group type: EXPERIMENTAL
Intervention: low‐dose phentolamine
Number of subjects: 14
Study 8942402 — intervention group
Group type: EXPERIMENTAL
Intervention: high‐dose phentolamine
Number of subjects: 14
Study 8942402 — intervention group
Group type: COMPARATOR
Intervention: control (no drug)
Number of subjects: 14
Study 1749945 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg gold sodium thiomalate (GST) administered intramuscularly for 12 months
Number of subjects: 102
Study 1749945 — intervention group
Group type: COMPARATOR
Intervention: 15 mg methotrexate (MTX) administered intramuscularly for 12 months
Number of subjects: 102
Study 1749945 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg gold sodium thiomalate (GST)
Number of subjects: 102
Study 1749945 — intervention group
Group type: COMPARATOR
Intervention: 15 mg methotrexate (MTX)
Number of subjects: 102
Study 1749945 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 102
Study 7200736 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 (PGE1) infusion (100‐150 ng/kg/minute)
Number of subjects: 0
Study 30586755 — intervention group
Group type: EXPERIMENTAL
Intervention: Impella device
Number of subjects: 372
Study 30586755 — intervention group
Group type: COMPARATOR
Intervention: Intra-aortic balloon pump (IABP)
Number of subjects: 372
Study 28287799 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized normative feedback (PNF) intervention
Number of subjects: 784
Study 28287799 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 784
Study 26867477 — intervention group
Group type: EXPERIMENTAL
Intervention: Mallinckrodt tube (ML)
Number of subjects: 26
Study 26867477 — intervention group
Group type: COMPARATOR
Intervention: Intersurgical tube (IS)
Number of subjects: 26
Study 24559754 — intervention group
Group type: EXPERIMENTAL
Intervention: Tracheostomy placement
Number of subjects: 51
Study 20963411 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccination with WT1-, Pr3-, and MUC1-derived peptides combined with CpG7909 and MontanideISA51
Number of subjects: 9
Study 19862403 — intervention group
Group type: COMPARATOR
Intervention: Aegis + control (phosphoric acid etch only)
Number of subjects: 90
Study 19862403 — intervention group
Group type: EXPERIMENTAL
Intervention: Aegis + Optibond Solo Plus
Number of subjects: 90
Study 19862403 — intervention group
Group type: EXPERIMENTAL
Intervention: Various sealants and adhesive agents
Number of subjects: 90
Study 19862403 — intervention group
Group type: EXPERIMENTAL
Intervention: Fissure morphology
Number of subjects: 90
Study 19862403 — intervention group
Group type: EXPERIMENTAL
Intervention: Microleakage and penetrability correlation
Number of subjects: 90
Study 18426091 — intervention group
Group type: EXPERIMENTAL
Intervention: Sub-maximum exercise at 1,700 meters altitude (EC)
Number of subjects: 9
Study 18426091 — intervention group
Group type: COMPARATOR
Intervention: Sub-maximum exercise at sea level (MSL)
Number of subjects: 9
Study 15687413 — intervention group
Group type: COMPARATOR
Intervention: Topiramate
Number of subjects: 0
Study 11495449 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycobacterium habana vaccine (1.5 mg)
Number of subjects: 67
Study 11495449 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycobacterium habana vaccine
Number of subjects: 67
Study 9743309 — intervention group
Group type: EXPERIMENTAL
Intervention: VIP (four cycles of etoposide, ifosfamide, cisplatin)
Number of subjects: 84
Study 9743309 — intervention group
Group type: EXPERIMENTAL
Intervention: BEP (four cycles of bleomycin, etoposide, cisplatin)
Number of subjects: 84
Study 9743309 — intervention group
Group type: EXPERIMENTAL
Intervention: VIP
Number of subjects: 84
Study 9743309 — intervention group
Group type: EXPERIMENTAL
Intervention: BEP
Number of subjects: 84
Study 7594346 — intervention group
Group type: EXPERIMENTAL
Intervention: Half-dose q.d. (30 mg/day)
Number of subjects: 71
Study 7594346 — intervention group
Group type: COMPARATOR
Intervention: Weekend full-dose (30 mg on weekends)
Number of subjects: 71
Study 2643641 — intervention group
Group type: EXPERIMENTAL
Intervention: Karaya gum patches containing salicylic acid
Number of subjects: 0
Study 2643641 — intervention group
Group type: COMPARATOR
Intervention: Control patches (without salicylic acid)
Number of subjects: 0
Study 1101595 — intervention group
Group type: EXPERIMENTAL
Intervention: Infraclavicular puncture of the subclavian vein
Number of subjects: 125
Study 1101595 — intervention group
Group type: COMPARATOR
Intervention: Basilic vein catheterization
Number of subjects: 125
Study 31088569 — intervention group
Group type: EXPERIMENTAL
Intervention: CHW-led multimedia intervention
Number of subjects: 408
Study 31088569 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control arm
Number of subjects: 408
Study 27614662 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Therapy (CT) with adjunctive Memory Support Intervention (CT + Memory Support)
Number of subjects: 48
Study 27614662 — intervention group
Group type: COMPARATOR
Intervention: CT-as-usual
Number of subjects: 48
Study 25222484 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist Brief Intervention (TBI)
Number of subjects: 1053
Study 25222484 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer Brief Intervention (CBI)
Number of subjects: 1053
Study 25222484 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 1053
Study 23219236 — intervention group
Group type: EXPERIMENTAL
Intervention: Mtb72F/AS02
Number of subjects: 38
Study 23219236 — intervention group
Group type: COMPARATOR
Intervention: AS02
Number of subjects: 38
Study 21762179 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol (0.5 mg/kg)
Number of subjects: 64
Study 21762179 — intervention group
Group type: COMPARATOR
Intervention: Fruit juice (control)
Number of subjects: 64
Study 18652266 — intervention group
Group type: EXPERIMENTAL
Intervention: Adper Prompt L-Pop (self-etching adhesive)
Number of subjects: 180
Study 18652266 — intervention group
Group type: EXPERIMENTAL
Intervention: Clearfil SE Bond (self-etching adhesive)
Number of subjects: 180
Study 18652266 — intervention group
Group type: EXPERIMENTAL
Intervention: One Step (etch-and-rinse bonding agent)
Number of subjects: 180
Study 18652266 — intervention group
Group type: EXPERIMENTAL
Intervention: 37% H3PO4 etching for 15 s
Number of subjects: 180
Study 18652266 — intervention group
Group type: EXPERIMENTAL
Intervention: 37% H3PO4 etching for 15 s and 5% NaOCl aq application for 2 min
Number of subjects: 180
Study 18652266 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific adhesive mentioned)
Number of subjects: 180
Study 16707519 — intervention group
Group type: EXPERIMENTAL
Intervention: Aphakic and pseudophakic patients after congenital cataract surgery
Number of subjects: 43
Study 16707519 — intervention group
Group type: COMPARATOR
Intervention: Healthy age and sex matched controls
Number of subjects: 43
Study 16707519 — intervention group
Group type: EXPERIMENTAL
Intervention: Aphakic eyes with IOL implanted at congenital cataract surgery
Number of subjects: 43
Study 16707519 — intervention group
Group type: EXPERIMENTAL
Intervention: Aphakic eyes with secondary IOL implantation
Number of subjects: 43
Study 12886826 — intervention group
Group type: EXPERIMENTAL
Intervention: CLD i.v., 300 mg/2 weeks and oral calcium carbonate (500 mg x 2/day) and vitamin D3 (400 IU x 2/day)
Number of subjects: 84
Study 12886826 — intervention group
Group type: EXPERIMENTAL
Intervention: CLD i.m., 100 mg/week and the same doses of calcium and vitamin D3 as group A
Number of subjects: 84
Study 12886826 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving only calcium and vitamin D3
Number of subjects: 84
Study 12886826 — intervention group
Group type: EXPERIMENTAL
Intervention: CLD i.v. (group A)
Number of subjects: 84
Study 12886826 — intervention group
Group type: EXPERIMENTAL
Intervention: CLD i.v. (group A) and CLD i.m. (group B)
Number of subjects: 84
Study 10845828 — intervention group
Group type: EXPERIMENTAL
Intervention: CsA monotherapy
Number of subjects: 143
Study 10845828 — intervention group
Group type: EXPERIMENTAL
Intervention: CsA in a single daily dose
Number of subjects: 143
Study 9366890 — intervention group
Group type: EXPERIMENTAL
Intervention: Transurethral resection of the prostate (TURP)
Number of subjects: 0
Study 9366890 — intervention group
Group type: COMPARATOR
Intervention: Laser vaporization prostatectomy
Number of subjects: 0
Study 9366890 — intervention group
Group type: COMPARATOR
Intervention: EuroQol
Number of subjects: 0
Study 9366890 — intervention group
Group type: COMPARATOR
Intervention: SF-36
Number of subjects: 0
Study 9366890 — intervention group
Group type: COMPARATOR
Intervention: American Urological Association symptom score
Number of subjects: 0
Study 9366890 — intervention group
Group type: COMPARATOR
Intervention: Bothersome index
Number of subjects: 0
Study 8439201 — intervention group
Group type: COMPARATOR
Intervention: Whole blood (no filter)
Number of subjects: 57
Study 8439201 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood passed through a leucocyte filter
Number of subjects: 57
Study 3818144 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirenzepin (20 mg intravenous injection)
Number of subjects: 0
Study 3818144 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31357402 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-salt bread (0.3 g salt/100 g) as part of a reduced-salt diet
Number of subjects: 97
Study 31357402 — intervention group
Group type: COMPARATOR
Intervention: Usual-salt dietary period
Number of subjects: 97
Study 29485064 — intervention group
Group type: EXPERIMENTAL
Intervention: 56 Gy (16 fractions of 3.5 Gy; arm A)
Number of subjects: 160
Study 29485064 — intervention group
Group type: EXPERIMENTAL
Intervention: 67 Gy (25 fractions of 2.68 Gy; arm B)
Number of subjects: 160
Study 27021174 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 60
Study 27021174 — intervention group
Group type: COMPARATOR
Intervention: Sufentanil
Number of subjects: 60
Study 25139150 — intervention group
Group type: EXPERIMENTAL
Intervention: Naftopidil 50 mg/day
Number of subjects: 103
Study 25139150 — intervention group
Group type: EXPERIMENTAL
Intervention: Naftopidil 50 mg/day plus Celecoxib 200 mg
Number of subjects: 103
Study 25139150 — intervention group
Group type: COMPARATOR
Intervention: Celecoxib 200 mg
Number of subjects: 103
Study 21858589 — intervention group
Group type: EXPERIMENTAL
Intervention: Late course accelerated hyperfraction (LCAF) three-dimensional conformal radiotherapy
Number of subjects: 98
Study 21858589 — intervention group
Group type: COMPARATOR
Intervention: Conventional fraction (CF) three-dimensional conformal radiotherapy
Number of subjects: 98
Study 22163454 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic circulator
Number of subjects: 16
Study 22163454 — intervention group
Group type: COMPARATOR
Intervention: Control (without the circulator)
Number of subjects: 16
Study 17631866 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisdexamfetamine dimesylate (LDX: 30, 50, or 70 mg)
Number of subjects: 52
Study 17631866 — intervention group
Group type: COMPARATOR
Intervention: Mixed amphetamine salts extended-release (MAS XR: 10, 20, or 30 mg)
Number of subjects: 52
Study 17631866 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 15740944 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-pressure suction applied to underwater seal drains postoperatively
Number of subjects: 239
Study 15740944 — intervention group
Group type: COMPARATOR
Intervention: No suction applied to underwater seal drains postoperatively
Number of subjects: 239
Study 12045762 — intervention group
Group type: EXPERIMENTAL
Intervention: Fränkel Functional Regulator‐II (FR‐II) treatment for 18 months
Number of subjects: 56
Study 12045762 — intervention group
Group type: COMPARATOR
Intervention: Control group (not treated during the observation period)
Number of subjects: 56
Study 10208142 — intervention group
Group type: EXPERIMENTAL
Intervention: Nandrolone decanoate, 100 mg by intramuscular injection once a week for 6 months
Number of subjects: 29
Study 10208142 — intervention group
Group type: COMPARATOR
Intervention: Placebo by intramuscular injection once a week for 6 months
Number of subjects: 29
Study 10208142 — intervention group
Group type: EXPERIMENTAL
Intervention: Nandrolone decanoate
Number of subjects: 29
Study 10208142 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 8903607 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-potassium-sparing diuretics
Number of subjects: 371
Study 8903607 — intervention group
Group type: COMPARATOR
Intervention: Potassium-sparing diuretic therapy
Number of subjects: 371
Study 2469097 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine treatment
Number of subjects: 13
Study 2469097 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 31857335 — intervention group
Group type: EXPERIMENTAL
Intervention: Lowered tackle height setting (Championship Cup, 36 games)
Number of subjects: 126
Study 31857335 — intervention group
Group type: COMPARATOR
Intervention: Standard tackle height setting (Championship, 90 games)
Number of subjects: 126
Study 31280434 — intervention group
Group type: EXPERIMENTAL
Intervention: Panitumumab (6 mg/kg) plus docetaxel (50 mg/m2) and cisplatin (50 mg/m2) every 2 weeks until disease progression, unacceptable toxicity, or patient withdrawal
Number of subjects: 44
Study 29582422 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.0 mg hyperbaric bupivacaine plus 15 μg fentanyl
Number of subjects: 30
Study 29582422 — intervention group
Group type: COMPARATOR
Intervention: 2.5 mg hyperbaric bupivacaine
Number of subjects: 30
Study 26418629 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal therapeutic program (added to standard care)
Number of subjects: 49
Study 26418629 — intervention group
Group type: COMPARATOR
Intervention: Standard care (Control Group)
Number of subjects: 49
Study 26402815 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Vibrating Exercise (RVE)
Number of subjects: 11
Study 26402815 — intervention group
Group type: EXPERIMENTAL
Intervention: RVE with high-protein supplement diet (NeX group)
Number of subjects: 11
Study 26402815 — intervention group
Group type: COMPARATOR
Intervention: Bed rest (Control group)
Number of subjects: 11
Study 23934737 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixture of ellagitannin-rich berries (specific dosage and duration not mentioned)
Number of subjects: 0
Study 23934737 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 21035871 — intervention group
Group type: EXPERIMENTAL
Intervention: Contact technique
Number of subjects: 50
Study 21035871 — intervention group
Group type: COMPARATOR
Intervention: Immersion technique
Number of subjects: 50
Study 19060417 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin (20 mg/day for 1 week)
Number of subjects: 0
Study 19060417 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (20 mg/day for 1 week)
Number of subjects: 0
Study 19060417 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin and fasudil (combination therapy)
Number of subjects: 0
Study 19060417 — intervention group
Group type: COMPARATOR
Intervention: Fasudil (selective Rho-kinase inhibitor)
Number of subjects: 0
Study 19060417 — intervention group
Group type: COMPARATOR
Intervention: Atorvastatin
Number of subjects: 0
Study 19060417 — intervention group
Group type: COMPARATOR
Intervention: Statins (atorvastatin, pitavastatin, pravastatin at 10 micromol/L)
Number of subjects: 0
Study 17132351 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-held guideline with written explicit exhortation to challenge care
Number of subjects: 236
Study 17132351 — intervention group
Group type: COMPARATOR
Intervention: Standard information
Number of subjects: 236
Study 17132351 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-held guideline
Number of subjects: 236
Study 12923753 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided imagery audiotapes (GI)
Number of subjects: 84
Study 12923753 — intervention group
Group type: EXPERIMENTAL
Intervention: Music audiotapes (MU)
Number of subjects: 84
Study 12923753 — intervention group
Group type: COMPARATOR
Intervention: Standard care (C)
Number of subjects: 84
Study 10895920 — intervention group
Group type: EXPERIMENTAL
Intervention: EMT-Bs evaluating wounds for repair
Number of subjects: 11
Study 10895920 — intervention group
Group type: EXPERIMENTAL
Intervention: EMT-Bs evaluating forearm wounds
Number of subjects: 11
Study 10895920 — intervention group
Group type: EXPERIMENTAL
Intervention: EMT-Bs identifying patients requiring tetanus prophylaxis
Number of subjects: 11
Study 10895920 — intervention group
Group type: COMPARATOR
Intervention: Agreement between EMT-Bs and physicians on wound exclusion criteria
Number of subjects: 11
Study 9065539 — intervention group
Group type: EXPERIMENTAL
Intervention: Respiratory chain enzyme activities in lymphocyte mitochondria from patients with Alzheimer's disease (AD)
Number of subjects: 63
Study 9065539 — intervention group
Group type: COMPARATOR
Intervention: Respiratory chain enzyme activities in lymphocyte mitochondria from healthy controls
Number of subjects: 63
Study 8155929 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide (200 micrograms daily)
Number of subjects: 18
Study 8155929 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide (800 micrograms daily)
Number of subjects: 18
Study 8155929 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 3788644 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 558
Study 3788644 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavior therapy
Number of subjects: 558
Study 3788644 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 558
Study 3788644 — intervention group
Group type: COMPARATOR
Intervention: Waiting list
Number of subjects: 558
Study 31715262 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold stimulus
Number of subjects: 50
Study 31715262 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat stimulus
Number of subjects: 50
Study 31715262 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure pain threshold (PPT) test stimulus
Number of subjects: 50
Study 31715262 — intervention group
Group type: EXPERIMENTAL
Intervention: Sham conditioning stimuli
Number of subjects: 50
Study 30473365 — intervention group
Group type: EXPERIMENTAL
Intervention: SEHER intervention delivered by lay counsellor (SM group)
Number of subjects: 14000
Study 30473365 — intervention group
Group type: COMPARATOR
Intervention: SEHER intervention delivered by teacher (TSM group)
Number of subjects: 14000
Study 27068361 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin analogues (detemir/aspart)
Number of subjects: 114
Study 27068361 — intervention group
Group type: COMPARATOR
Intervention: Human insulin (NPH/regular)
Number of subjects: 114
Study 24597906 — intervention group
Group type: EXPERIMENTAL
Intervention: AVD optimization using impedance cardiography (ICG)
Number of subjects: 37
Study 24597906 — intervention group
Group type: COMPARATOR
Intervention: Factory setting group (AVDfab)
Number of subjects: 37
Study 21762160 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-affirmation manipulation
Number of subjects: 220
Study 21762160 — intervention group
Group type: COMPARATOR
Intervention: Equivalently active control task
Number of subjects: 220
Study 21105622 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin (75 units/kg intravenously) before clamping of the artery
Number of subjects: 48
Study 21105622 — intervention group
Group type: COMPARATOR
Intervention: Control group (no heparin)
Number of subjects: 48